This company has so much potential, it is ridiculous. Usually companies when done their R&D are choked with debt and really hope for a breakthrough to make it.
NOT THIS COMPANY FOLKS! I've never seen a cleaner balance sheet in an entry level public firm that just done 36 months of R&D! This makes us a VERY attractive buy for many established companies in this industry AND/OR an investment prospect.
A) Buyout
B) Institutional Investors
Either option means CRAZY profit to holders from this level.
News 
Market Data 
Discover 
